Pharma and biotech partners
You need differentiated, de-risked metabolic assets. We're designed to deliver programs through preclinical gates and into your hands through options, licenses, co-development, or asset transactions.
Partner & Invest
Whether you're building a metabolic pipeline or a life-science portfolio, let's find out if there's a fit.
01 / Who we talk with
You need differentiated, de-risked metabolic assets. We're designed to deliver programs through preclinical gates and into your hands through options, licenses, co-development, or asset transactions.
ApaisBio is a focused, asset-centered company for weight-loss and metabolic programs built on our technology partner Biosortia's platform. We're glad to start a conversation; any investment information is shared privately and only where appropriate, never on this website.
If your science, data, or computing capabilities could speed gut-restricted metabolic drug discovery, we'd like to hear from you.
02 / Contact ApaisBio
Contact us→Please note
Please don't send confidential information through the contact form or email. Confidential discussions happen under a signed confidentiality agreement. Nothing on this website is an offer to sell or a solicitation of an offer to buy any security.
03 / What happens next